Li M, Gao Z, Wang S, Zhao Y, Xie H
Oncol Rep. 2023; 50(1).
PMID: 37203408
PMC: 10236263.
DOI: 10.3892/or.2023.8569.
Pan D, Fang X, Li J
Medicina (Kaunas). 2023; 59(2).
PMID: 36837615
PMC: 9959126.
DOI: 10.3390/medicina59020414.
Hassan M, Nasr S, Amin N, El-Ahwany E, Zoheiry M, ElZallat M
Noncoding RNA Res. 2023; 8(2):155-163.
PMID: 36632614
PMC: 9826835.
DOI: 10.1016/j.ncrna.2022.12.006.
Soheilifar M, Pornour M, Saidijam M, Najafi R, Jalilian F, Keshmiri Neghab H
Bioimpacts. 2022; 12(4):349-358.
PMID: 35975203
PMC: 9376166.
DOI: 10.34172/bi.2021.23571.
Jeon H, Seo S, Kim T, Ryu J, Kong H, Jang S
Curr Issues Mol Biol. 2022; 44(1):288-300.
PMID: 35723400
PMC: 8928998.
DOI: 10.3390/cimb44010021.
An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.
Guz M, Jeleniewicz W, Cybulski M
Int J Mol Sci. 2022; 23(3).
PMID: 35163157
PMC: 8835968.
DOI: 10.3390/ijms23031234.
A Review on the Role of miR-1290 in Cell Proliferation, Apoptosis and Invasion.
Ghafouri-Fard S, Khoshbakht T, Hussen B, Taheri M, Samadian M
Front Mol Biosci. 2022; 8:763338.
PMID: 35004844
PMC: 8740132.
DOI: 10.3389/fmolb.2021.763338.
The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells.
Puschel J, Dubrovska A, Gorodetska I
Cancers (Basel). 2021; 13(18).
PMID: 34572930
PMC: 8472046.
DOI: 10.3390/cancers13184703.
Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L, Cai Y, Chen X, Zhu Y, Cai J
BMC Cancer. 2021; 21(1):989.
PMID: 34479528
PMC: 8417985.
DOI: 10.1186/s12885-021-08729-0.
ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma.
Gong J, Tang W, Lv B, Zhang S, Fan T, Gao G
Biomed Res Int. 2021; 2021:3381957.
PMID: 34350290
PMC: 8328732.
DOI: 10.1155/2021/3381957.
Low expression of miRNA-1290 associated with local invasion and recurrence in sacral chordoma.
Wang Y, Chen K, Chen H, Zhang K, Lu J, Mao H
Int J Clin Exp Pathol. 2020; 10(11):10934-10940.
PMID: 31966437
PMC: 6965869.
Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M, Sawada K, Nakamura K, Yoshimura A, Miyamoto M, Shimizu A
J Ovarian Res. 2018; 11(1):81.
PMID: 30219071
PMC: 6138886.
DOI: 10.1186/s13048-018-0458-0.
Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.
Zavesky L, Jandakova E, Weinberger V, Minar L, Hanzikova V, Duskova D
Reprod Sci. 2018; 26(4):510-522.
PMID: 29779470
PMC: 6421628.
DOI: 10.1177/1933719118776808.
MicroRNA-mediated interacting circuits predict hypoxia and inhibited osteogenesis of stem cells, and dysregulated angiogenesis are involved in osteonecrosis of the femoral head.
Kao G, Tu Y, Sung P, Wang F, Lu Y, Wu C
Int Orthop. 2018; 42(7):1605-1614.
PMID: 29700584
DOI: 10.1007/s00264-018-3895-x.
miR-1290 promotes lung adenocarcinoma cell proliferation and invasion by targeting SOCS4.
Xiao X, Yang D, Gong X, Mo D, Pan S, Xu J
Oncotarget. 2018; 9(15):11977-11988.
PMID: 29552286
PMC: 5844722.
DOI: 10.18632/oncotarget.24046.
miR-1290 Contributes to Colorectal Cancer Cell Proliferation by Targeting INPP4B.
Ma Q, Wang Y, Zhang H, Wang F
Oncol Res. 2017; 26(8):1167-1174.
PMID: 28915933
PMC: 7844673.
DOI: 10.3727/096504017X15051741798389.
miR-1290 Is a Biomarker in DNA-Mismatch-Repair-Deficient Colon Cancer and Promotes Resistance to 5-Fluorouracil by Directly Targeting hMSH2.
Ye L, Jiang T, Shao H, Zhong L, Wang Z, Liu Y
Mol Ther Nucleic Acids. 2017; 7:453-464.
PMID: 28624221
PMC: 5443909.
DOI: 10.1016/j.omtn.2017.05.006.
Altered Expressions of miR-1238-3p, miR-494, miR-6069, and miR-139-3p in the Formation of Chronic Brucellosis.
Budak F, Bal S, Tezcan G, Akalin H, Goral G, Oral H
J Immunol Res. 2016; 2016:4591468.
PMID: 27722176
PMC: 5046029.
DOI: 10.1155/2016/4591468.
Mechanism analysis of colorectal cancer according to the microRNA expression profile.
Li H, Zhang H, Lu G, Li Q, Gu J, Song Y
Oncol Lett. 2016; 12(4):2329-2336.
PMID: 27698796
PMC: 5038387.
DOI: 10.3892/ol.2016.5027.
Profiling analysis of circulating microRNA expression in cervical cancer.
Nagamitsu Y, Nishi H, Sasaki T, Takaesu Y, Terauchi F, Isaka K
Mol Clin Oncol. 2016; 5(1):189-194.
PMID: 27330796
PMC: 4906571.
DOI: 10.3892/mco.2016.875.